摘要：SummaryMany biosynthetic gene clusters (BGCs) require heterologous expression to realize their genetic potential, including silent and metagenomic BGCs. Although the engineeredStreptomyces coelicolorM1152 is a widely used host for heterologous expression of BGCs, a systemic understanding of how its genetic modifications affect the metabolism is lacking and limiting further development. We performed a comparative analysis of M1152 and its ancestor M145, connecting information from proteomics, transcriptomics, and cultivation data into a comprehensive picture of the metabolic differences between these strains. Instrumental to this comparison was the application of an improved consensus genome-scale metabolic model (GEM) ofS. coelicolor. Although many metabolic patterns are retained in M1152, we find that this strain suffers from oxidative stress, possibly caused by increased oxidative metabolism. Furthermore, precursor availability is likely not limiting polyketide production, implying that other strategies could be beneficial for further development ofS. coelicolorfor heterologous production of novel compounds.Graphical AbstractDisplay OmittedHighlights•Time-series transcriptomics and proteomics of S. coelicolor M145 and M1152•Application of GEM to interpret changes in the proteome on the systems level•Limited effect of improved precursor supply on enhanced production in M1152•Reduced rate of germicidin in M1152 suggests a need for other expression hostsSystems Biology; Omics; Metabolic Engineering
